Table 2. The number of patients in NPI+ classes receiving adjuvant systemic therapy.
|
Endocrine therapy |
Chemotherapy |
|||
|---|---|---|---|---|
| Yes | No | Yes | No | |
|
Luminal A | ||||
| Group 1 | 88 | 139 | 13 | 213 |
| Group 2 | 62 | 18 | 13 | 67 |
| Group 3 |
10 |
5 |
5 |
10 |
|
Luminal N | ||||
| Group 1 | 35 | 71 | 7 | 98 |
| Group 2 |
10 |
4 |
4 |
10 |
|
Luminal B | ||||
| Group 1 | 23 | 29 | 0 | 52 |
| Group 2 |
40 |
4 |
6 |
39 |
|
Basal p53 altered | ||||
| Group 1 | 15 | 63 | 37 | 41 |
| Group 2 |
4 |
21 |
21 |
5 |
|
Basal p53 normal | ||||
| Group 1 | 11 | 32 | 19 | 24 |
| Group 2 |
6 |
19 |
15 |
10 |
|
HER2+/ER+ | ||||
| Group 1 | 17 | 10 | 4 | 23 |
| Group 2 |
16 |
8 |
8 |
16 |
|
HER2+/ER− | ||||
| Group 1 | 18 | 23 | 12 | 29 |
| Group 2 | 4 | 11 | 9 | 6 |
| Group 3 | 3 | 6 | 7 | 2 |
Abbreviations: ER=oestrogen receptor; NPI+=Nottingham prognostic index plus.